Skip to content
10-Q

Quarterly Report

Biostar Pharmaceuticals, Inc.

0001185185-17-002435

← back to feed
Filed
Nov 20, 2017 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2017 · Nov 20, 2017 2.64M sh
Shares Diluted Q3 2017 · Sep 30, 2017 2.64M sh
Shares Diluted Q3 2017 · Sep 30, 2017 2.64M sh
Shares Diluted Q3 2017 · Sep 30, 2016 2.21M sh
Shares Diluted Q3 2017 · Sep 30, 2016 2.21M sh
Capex Q3 2017 · Sep 30, 2017 $4.41M
Capex Q3 2017 · Sep 30, 2016 $0
Operating Cash Flow Q3 2017 · Sep 30, 2017 $4.59M
Operating Cash Flow Q3 2017 · Sep 30, 2016 $911.06K
Short Term Debt Q3 2017 · Sep 30, 2017 $2.43M
Short Term Debt Q3 2017 · Sep 30, 2017 ¥20M
Short Term Debt Q3 2017 · Dec 31, 2016 $2.33M
Short Term Debt Q3 2017 · Dec 31, 2016 ¥20M
Cash And Equivalents Q3 2017 · Sep 30, 2017 $364.97K
Cash And Equivalents Q3 2017 · Dec 31, 2016 $173.29K
Cash And Equivalents Q3 2017 · Sep 30, 2016 $659.36K
Cash And Equivalents Q3 2017 · Dec 31, 2015 $38.9K
Stockholders Equity Q3 2017 · Sep 30, 2017 $36.15M
Stockholders Equity Q3 2017 · Dec 31, 2016 $36.88M
Current Liabilities Q3 2017 · Sep 30, 2017 $5.28M
Current Liabilities Q3 2017 · Dec 31, 2016 $5.62M
Current Assets Q3 2017 · Sep 30, 2017 $996.64K
Current Assets Q3 2017 · Dec 31, 2016 $7.37M
Total Assets Q3 2017 · Sep 30, 2017 $41.43M
Total Assets Q3 2017 · Dec 31, 2016 $42.5M
Eps Diluted Q3 2017 · Sep 30, 2017 −$0.05
Eps Diluted Q3 2017 · Sep 30, 2017 −$0.93
Eps Diluted Q3 2017 · Sep 30, 2016 −$0.71
Eps Diluted Q3 2017 · Sep 30, 2016 −$4.11
Eps Basic Q3 2017 · Sep 30, 2017 −$0.05
Eps Basic Q3 2017 · Sep 30, 2017 −$0.93
Eps Basic Q3 2017 · Sep 30, 2016 −$0.71
Eps Basic Q3 2017 · Sep 30, 2016 −$4.11
Sga Expense Q3 2017 · Sep 30, 2017 $558.71K
Sga Expense Q3 2017 · Sep 30, 2017 $2.84M
Sga Expense Q3 2017 · Sep 30, 2016 $488.14K
Sga Expense Q3 2017 · Sep 30, 2016 $1.72M
Net Income Q3 2017 · Sep 30, 2017 −$125.19K
Net Income Q3 2017 · Sep 30, 2017 −$2.45M
Net Income Q3 2017 · Sep 30, 2016 −$1.56M
Net Income Q3 2017 · Sep 30, 2016 −$9.09M
Operating Income Q3 2017 · Sep 30, 2017 −$573.38K
Operating Income Q3 2017 · Sep 30, 2017 −$3.14M
Operating Income Q3 2017 · Sep 30, 2016 −$1.96M
Operating Income Q3 2017 · Sep 30, 2016 −$9.49M
Gross Profit Q3 2017 · Sep 30, 2017 $0
Gross Profit Q3 2017 · Sep 30, 2017 $0
Gross Profit Q3 2017 · Sep 30, 2016 $308.06K
Gross Profit Q3 2017 · Sep 30, 2016 $951.92K
Cost Of Revenue Q3 2017 · Sep 30, 2017 $0
Cost Of Revenue Q3 2017 · Sep 30, 2017 $0
Cost Of Revenue Q3 2017 · Sep 30, 2016 $336.87K
Cost Of Revenue Q3 2017 · Sep 30, 2016 $1.11M
Revenue Q3 2017 · Sep 30, 2017 $0
Revenue Q3 2017 · Sep 30, 2017 $0
Revenue Q3 2017 · Sep 30, 2016 $644.93K
Revenue Q3 2017 · Sep 30, 2016 $2.07M